Authors: Aoife Kiely, Research Communications Officer at Alzheimer’s Society (London, UK)
Any researcher writing a grant application, research paper or report to a funding body will tell you how important it is to spot the gaps in your research. What is the gap in your dementia research? Maybe you use transgenic mice, cell lines or stem cells, perhaps a combination – but are these enough? Are these systems able to come close enough to show you what has really happened in the brains of people with dementia? Have you considered investigating your protein of interest or disease mechanism in post-mortem human brain tissue?
An invaluable resource
It has never been easier or faster to apply for high-quality brain tissue accompanied with detailed medical history. Brains for Dementia Research (BDR) was established in 2007 in collaboration with Alzheimer’s Society and Alzheimer’s Research UK (London and Cambridge, UK, respectively) in response to the shortage of good-quality brain tissue for research.